Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

Overview of attention for article published in Clinical Cancer Research, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 35 X posts from 24 X users, with an upper bound of 110,830 followers.

RT @CCR_AACR: If you want more from #AACR24 AR and prostate cancer session speaker Scott Dehm, be sure to read his recent coauthored paper…

If you want more from #AACR24 AR and prostate cancer session speaker Scott Dehm, be sure to read his recent coauthored paper on a similar topic. https://t.co/wLxG4zNVN1 @AACR https://t.co/bE9L48alif

RRIDs were included in the Clinical Cancer Research paper "Expression and Therapeutic Targeting of TROP-2 in…" (https://t.co/Jm5aDuFzi2). Thank you for making your #methodsmatter. #accelerateopenscience

Targeting TROP2 in treatment resistant prostate cancer. https://t.co/0T1atdpqRF

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 31 additional X posts.